NEW YORK, May 7, 2012 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that the Company and Aeterna Zentaris Inc.

The corporate reporting season, a trudge through Wall Street's second quarter results, has been met with vigorous approval, it seems, in Asian markets. While U.S.

Asian markets climbed higher Friday, following U.S.

The strength of the U.S. economic recovery is showing signs of strain this week with rising unemployment undermining improvements. Although U.S. markets have made monthly gains March, April and May, the U.S. Department of Labor said unemployment rose to 9.4 percent last month.

Asian and European markets rose Thursday, a day after a gain in U.S. markets that shrugged off a dismal first-quarter report. The U.S. government said the gross domestic product fell 6.1 percent in the first quarter.